Probacti Caps
Natural health product licensed in Canada
- Licence holder
- Lallemand Health Solutions (Institut Rosell)
- NPN or DIN-HM
- 80079282
- Status
- Inactive licence
- Licence date
- 28 July 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactococcus lactis Source : Lactococcus lactis - Strain R1058ND | 1.5 Milliard d'unités formatrices de colonie par gramme | Not calculated |
| Lactobacillus casei Source : Lactobacillus casei - Strain R0215ND | 0.75 Milliard d'unités formatrices de colonie par gramme | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Strain R0052ND | 0.375 Milliard d'unités formatrices de colonie par gramme | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Strain R0071ND | 0.375 Milliard d'unités formatrices de colonie par gramme | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Fécule de pomme de terre, Fructooligosaccharides
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 6 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of Probiotics. Helps support intestinal/gastrointestinal health Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occurs and/or persists beyond 3 days, discontinue use and consult a health care practitioner. This product has come into contact with milk and soy. If you have milk or soy allergy do not use this product.
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
Source
Official Health Canada record, licence 80079282
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.